01P — Medpace Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual income statement for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,142	1,460	1,886	2,109	2,530
Cost of Revenue
Gross Profit	328	432	525	656	761
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	944	1,181	1,549	1,662	1,995
Operating Profit	199	279	337	447	535
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	202	283	336	476	542
Provision for Income Taxes
Net Income After Taxes	182	245	283	404	451
Net Income Before Extraordinary Items
Net Income	182	245	283	404	451
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	181	245	283	404	451
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.81	7.28	8.88	12.6	15.3